Ketamin

Lohankhapedia (自由的百科全書) 欲共你講..。
跳至導覽 跳至搜尋
Ketamin
(S)-Ketamine ball-and-stick model
Clinical data
Trade names Ketalar, others
Synonyms CI-581; CL-369; CM-52372-2[7]
AHFS/Drugs.com Monograph
data
Pregnancy
category
Addiction
liability
Low–moderate[1]
                                                      
Routes of
administration
Any[3][4][5][6]
Drug class NMDA receptor antagonists; General anesthetics; Dissociative hallucinogens; Analgesics; Antidepressants
ATC code
Legal status
Legal status
  • AU: S8 (Controlled)
  • BR: Class C1 (Other controlled substances)
  • CA: Schedule伊
  • DE: Unscheduled
  • UK: Class B
  • US: Schedule III
  • UN: Unscheduled
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability
  • Intravenous: 100%[5]
  • Intramuscular: 93%[5]
  • Epidural: 77%[10]
  • Intranasal: 45–50%[5][11]
  • Sublingual: 24–30%[5][12]
  • Rectal: 25–30%[11]
  • By mouth: 16–20%[5][11]
  • Protein binding 23多47%.[13]
    Metabolism

    Liverintestine (oral):[5][8][9]

    Metabolites
  • Norketamine
  • Dehydronorketamine
  • Hydroxynorketamine
  • Onset of action
  • Intravenous: seconds[14]
  • Intramuscular: 1–5 min[14][15]
  • Subcutaneous: 15–30 min[15]
  • Insufflation: 5–10 min[14]
  • By mouth: 15–30 min[14][15]
  • Elimination half-life
  • Ketamine: 2.5–3 hours[14][5]
  • Norketamine: 12 hours[15]
  • Duration of action
  • Intramuscular: 0.5–2 hours[15]
  • Insufflation: 45–60 min[14]
  • By mouth: 1–6+ hours[14][15]
  • Excretion
  • Urine: 91%[16]
  • Feces: 3%[16]
  • Identifiers
    CAS Number
    PubChem CID
    IUPHAR/BPS
    DrugBank
    ChemSpider
    UNII
    KEGG
    ChEBI
    ChEMBL
    Chemical and physical data
    Formula C13H16ClNO
    Molar mass 237.73 g͘mol−1
    3D model (JSmol)
    Chirality

    Racemic mixture:[14]

    Melting point [convert: invalid number]
      (verify)

    Ketamin ("Ke-tá-mín" 英語 (Eng-gí): ketamine), ()俗稱 (sio̍k-chheng) "K", "溪仔 (khe-á)", (si) (chi̍t) (khoán)麻藥 (bâ-io̍h) ()藥理學 (io̍h-lí-ha̍k) (siōng), ketamin ()NMDA受體 (siū-thé) (ê)結抗劑 (kiat-khòng-che) (antagonist)。 (Chit)款麻藥的副作用 (hù-chok-iōng) (ū)致力 (tì-le̍k)減退 (kiám-thè)嘔吐 (áu-thò͘)影響 (éng-hióng)呼吸 (ho͘-khip) (kap)消化 (siau-hoà)等等 (téng-téng)

    效果 (Hāu-kó)[修改]

    Ketamin (ē) (hō͘)食用者 (si̍t-ēng-chiá)產生 (sán-seng)改而感 (kái-lî-kám) (sense of dissocliation),chiō是自我 (chū-ngó͘) (tùi)身體 (sin-thé)脫離 (thoat-lî)感覺 (kám-kak)另外 (Lēng-gōa) (koh)造成 (chō-sêng)記憶 (kì-ek)喪失 (sòng-sit) (amnesia) 的影響, (kiam)視覺性 (sī-kak-sèng)換角 (hoān-kak) (hallucination).[18]

    利用 (Lī-iōng)方式 (hong-sek)[修改]

    (Chia̍h)ketamin的 (lâng)使用 (sú-iōng) (pún) (io̍h)的方式有包括 (pau-koat)食分 (chia̍h-hun) () (thàu) (hún)分支 (hun-ki) (ia̍h)大麻 (tōa-bâ)內面 (lāi-bīn); (ēng)篇仔 (phiⁿ-á) (khip) (hún); 佮lā佇液體 (e̍k-thé) (lāi)注射 (chù-siā) (téng)款。過量 (Kòe-liōng)的使用會產生 ()麻醉 (bâ-chùi)款的知覺 (ti-kak)減退.[18]

    參考 (Chham-khó)[修改]

    1. Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and Addictive Disorders". Chū Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd pán.). New York: McGraw-Hill Medical. pp. 374–375. ISBN 978-0-07-148127-4. Phencyclidine (PCP or angel dust) and ketamine (also known as special K) are structurally related drugs..。 their reinforcing properties and risks related to compulsive abuse  Vancouver style error: non-Latin character (help)
    2. "Ketamine (Ketalar) Use During Pregnancy". Drugs.com. 22 November 2019. goân-loē-iông tī 26 June 2020 hőng khó͘-pih. 18 May 2020 khòaⁿ--ê.  Unknown parameter |url-status= ignored (help)
    3. Bell RF, Eccleston C, Kalso EA (June 2017). "Ketamine as an adjuvant to opioids for cancer pain" (PDF). The Cochrane Database of Systematic Reviews. 6 (9): CD003351. doi:10.1002/14651858.CD003351.pub3. PMC 6481583Freely accessible Check |pmc= value (help). PMID 28657160. 
    4. Moyse DW, Kaye AD, Diaz JH, Qadri MY, Lindsay D, Pyati S (March 2017). "Perioperative Ketamine Administration for Thoracotomy Pain". Pain Physician. 20 (3): 173–184. PMID 28339431. 
    5. 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 Mathew SJ, Zarate Jr CA (25 November 2016). Ketamine for Treatment-Resistant Depression: The First Decade of Progress. Springer. pp. 8–10, 14–22. ISBN 978-3-319-42925-0. goân-loē-iông tī 8 September 2017 hőng khó͘-pih.  Unknown parameter |url-status= ignored (help); Vancouver style error: non-Latin character (help)
    6. Brayfield A, pian. (9 January 2017). "Ketamine Hydrochloride: Martindale: The Complete Drug Reference". MedicinesComplete. London, UK: Pharmaceutical Press. goân-loē-iông tī 28 August 2021 hőng khó͘-pih. 24 August 2017 khòaⁿ--ê.  Unknown parameter |url-status= ignored (help)
    7. Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 159–. ISBN 978-94-011-4439-1. goân-loē-iông tī 11 April 2017 hőng khó͘-pih.  Unknown parameter |url-status= ignored (help); Vancouver style error: non-Latin character (help)
    8. Hijazi Y, Boulieu R (July 2002). "Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes". Drug Metabolism and Disposition. 30 (7): 853–8. doi:10.1124/dmd.30.7.853. PMID 12065445.  Unknown parameter |s2cid= ignored (help)
    9. Ín-iōng chhò-gō͘: Bû-hāu ê <ref> tag; chhōe bô chí-miâ ê ref bûn-jī pmid27763887
    10. Kintz P (22 March 2014). Toxicological Aspects of Drug-Facilitated Crimes. Elsevier Science. pp. 87–. ISBN 978-0-12-416969-2. goân-loē-iông tī 8 September 2017 hőng khó͘-pih.  Unknown parameter |url-status= ignored (help)
    11. 11.0 11.1 11.2 Marland S, Ellerton J, Andolfatto G, Strapazzon G, Thomassen O, Brandner B, Weatherall A, Paal P (June 2013). "Ketamine: use in anesthesia". CNS Neurosci Ther. 19 (6): 381–9. doi:10.1111/cns.12072. PMC 6493613Freely accessible Check |pmc= value (help). PMID 23521979.  Vancouver style error: non-Latin character (help)
    12. Hashimoto K (October 2019). "Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective". Psychiatry and Clinical Neurosciences. 73 (10): 613–627. doi:10.1111/pcn.12902. PMC 6851782Freely accessible Check |pmc= value (help). PMID 31215725. 
    13. Dayton PG, Stiller RL, Cook DR, Perel JM (1983). "The binding of ketamine to plasma proteins: emphasis on human plasma". Eur J Clin Pharmacol. 24 (6): 825–31. doi:10.1007/BF00607095. PMID 6884418.  Unknown parameter |s2cid= ignored (help); Vancouver style error: non-Latin character (help)
    14. 14.0 14.1 14.2 14.3 14.4 14.5 14.6 14.7 Sinner B, Graf BM (2008). "Ketamine". Chū Schüttler J, Schwilden H. Modern Anesthetics. Handbook of Experimental Pharmacology. 182. pp. 313–33. doi:10.1007/978-3-540-74806-9_15. ISBN 978-3-540-72813-9. PMID 18175098.  Vancouver style error: non-Latin character (help)
    15. 15.0 15.1 15.2 15.3 15.4 15.5 Ín-iōng chhò-gō͘: Bû-hāu ê <ref> tag; chhōe bô chí-miâ ê ref bûn-jī Quibell2011
    16. 16.0 16.1 Ín-iōng chhò-gō͘: Bû-hāu ê <ref> tag; chhōe bô chí-miâ ê ref bûn-jī pmid4603048
    17. Sass W, Fusari S (1977). "Ketamine". Analytical Profiles of Drug Substances, volume 6. Analytical Profiles of Drug Substances. 6. Academic Press. pp. 297–322. doi:10.1016/S0099-5428(08)60347-0. ISBN 9780122608063. goân-loē-iông tī 8 February 2023 hőng khó͘-pih. 30 November 2020 khòaⁿ--ê.  Unknown parameter |url-status= ignored (help)
    18. 18.0 18.1 Amaranth Illuminare & Deborah S。 Romaine, pian. (2007). "ketamine". The Facts On File Encyclopedia of Health and Medicine. Volume 4. Facts On File. ISBN 0-8160-6063-0.